TEKMIRA PHARMACEUTICALS Corp | 2013 | FY | 3


(in C$)
 
December 31, 2013
   
December 31, 2012
 
Cash and cash equivalents
  $ 38,900,944     $ 149,058  
Accounts receivable
    10,840       1,025,306  
Accrued revenue
    225,892       2,361,836  
Accounts payable and accrued liabilities
    (1,889,480 )     (2,969,454 )
    $ 37,248,196     $ 566,746  

us-gaap:ScheduleOfIntercompanyForeignCurrencyBalancesTextBlock